Dr. Vinayak’s key areas of specialisation include paediatric and medical oncology, haemato oncology and bone marrow transplantation.
He has extensive experience in stem cell transplants for various haematological disorders like benign blood disorders, solid tumours, and haematological malignancies as well as neurological illnesses like multiple sclerosis.
He has vast experience in carrying out autologous and allogeneic stem cell transplants.
Dr. Vinayak has handled more than 1000 cases so far.
Training and Certifications
Dr. Vinayak has received advanced BMT and fellowship training under Dr William Hwang of SGH, Singapore
Dr. Vinayak was involved as the in-house consultant for setting up the BMT unit within the short span of 10 months.
He has served as a principal investigator for multiple international clinical trials.
He has received multiple awards and research grants from various professional societies.
Dr. Vinayak is a member of the Indian Society of Medical and Paediatric Oncology.
Osimertinib in EGFR-Mutated Advanced NSCLC. N Engl J Med. 2020 May 7;382(19):1864.
Tumour growth kinetics as a potential predictive and prognostic factor in carcinoma of the lung. Ann Transl Med. 2019 Jul;7(14):295.
Multiple chest wall swellings in adult Burkitt's lymphoma. The Lancet, 384(9961), 2244.
Relapsed Hodgkin's Lymphoma Presenting with Isolated Ulcerative Lesion on Base of Tongue. Indian J Hematol Blood Transfus. 2014;30(Suppl 1):349-352.
HCG - The Specialist in Cancer Care, India’s largest provider of cancer care, is at the forefront of the battle against cancer. Through its network of 24 comprehensive cancer centers, spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.